Improved Tumor Targeting with Multimeric Ligands

  • Author: Chemistry – A European Journal
  • Published Date: 17 March 2020
  • Source / Publisher: Chemistry – A European Journal
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
thumbnail image: Improved Tumor Targeting with Multimeric Ligands

Related Societies

Synthetic peptides are promising for the selective delivery of cytotoxic agents to tumor cells without harming healthy tissue. However, the targeting properties of monomeric peptides are not always sufficient to obtain tumor selectivity.


Norbert Sewald, Bielefeld University, Germany, Didier Boturyn, University Grenoble Alpes, France, and colleagues have developed anticancer conjugates (6, pictured below) that contain a multimeric ligand. This system contains a so-called RAFT (regioselectively addressable functionalized template) cyclodecapeptide scaffold and four copies of the cyclic Arg‐Gly‐Asp peptide c(RGDfK) (pictured in blue). This peptide targets the cancer-specific integrin αvβ3 present on the cell surface. Integrins are a type of receptor protein. The multivalent peptides bind better to the integrin than monomeric peptides, and, thus, provide a more specific tumor targeting.


The team connected the multimeric ligand to the anticancer agent cryptophycin‐55 glycinate (Cry-55gly, pictured in red) with a cleavable valine-citrulline (Val-Cit) linker (pictured in green) and a PEG-5 spacer. The resulting multimeric conjugate kills cancer cells expressing integrin αvβ3 more effectively than the analogous monomeric conjugate (5). The multimeric conjugate is non-toxic against control cells which do not express the integrin. According to the researchers, this targeting approach offers increased selectivity in the delivery of drugs.

 


 

 

Article Views: 1009

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH